Editas Medicine (EDIT) Research & Development (2015 - 2026)
Editas Medicine (EDIT) posted Research & Development of $19.78 million for Q3 2025, down 58.5% from $47.64 million a year earlier but up 22.2% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Research & Development (2015 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Research & Development at Editas Medicine was $111.16 million, down 49.5% year-over-year; for FY2024, it came in at $199.25 million, up 12.2% from FY2023.
- Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 15.5% (FY2019 to FY2024).
- In prior years, Editas Medicine's Research & Development was $177.65 million in FY2023 (+1.5%), $174.96 million in FY2022 (+22.8%), $142.51 million in FY2021 (-9.8%) and $158 million in FY2020 (+63.1%).
- Quarterly Research & Development has run from a low of $16.18 million in Q2 2025 to a high of $69.56 million in Q4 2023 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last four quarters, with an average decline of 5.2% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2024, with growth of 82.0%; the weakest was Q2 2025, with a decline of 70.2%.
- According to Business Quant data, Research & Development for the three prior quarters was $16.18 million (Q2 2025), $26.59 million (Q1 2025) and $48.61 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Editas Medicine | 385.55 Mn | -286.59 Mn | 8.20 Mn | 21.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.17 Mn |
| Jun 30, 2026 | 20.18 Mn |
| Mar 31, 2026 | 17.60 Mn |
| Dec 31, 2025 | 27.40 Mn |
| Sep 30, 2025 | 19.78 Mn |
| Jun 30, 2025 | 16.18 Mn |
| Mar 31, 2025 | 26.59 Mn |
| Dec 31, 2024 | 48.61 Mn |
| Sep 30, 2024 | 47.64 Mn |
| Jun 30, 2024 | 54.21 Mn |
| Mar 31, 2024 | 48.79 Mn |
| Dec 31, 2023 | 69.56 Mn |
| Sep 30, 2023 | 40.51 Mn |
| Jun 30, 2023 | 29.78 Mn |
| Mar 31, 2023 | 37.80 Mn |
| Dec 31, 2022 | 52.00 Mn |
| Sep 30, 2022 | 41.33 Mn |
| Jun 30, 2022 | 43.66 Mn |
| Mar 31, 2022 | 37.98 Mn |
| Dec 31, 2021 | 37.55 Mn |
API Access
Editas Medicine Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();